跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
LEVETIRACETAM QUALIGEN 100 MG/ML CONCENTRADO PARA SOLUCION PARA PEFUSION EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
LEVETIRACETAM QUALIGEN 100 MG/ML CONCENTRADO PARA SOLUCION PARA PEFUSION EFG
Approved
STANDARD
LEVETIRACETAM QUALIGEN 100 MG/ML CONCENTRADO PARA SOLUCION PARA PEFUSION EFG
Neuraxpharm Spain S.L.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Nov 23, 2020
Approval ID
c85f3333b29e4ced
Company
Neuraxpharm Spain S.L.
Type
Standard
Approval Details
Approval Id
c85f3333b29e4ced
Drug Cima Aemps Name
LEVETIRACETAM QUALIGEN 100 MG/ML CONCENTRADO PARA SOLUCION PARA PEFUSION EFG
Register Number
85591
Holder Company Name
Neuraxpharm Spain S.L.
Marketing Company Name
Neuraxpharm Spain S.L.
Authorization Date
2020-11-23
Dosage Form
CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN
Dose
100 mg/ml
Route Of Administration
VÍA INTRAVENOSA
Prescription Type
Uso Hospitalario
Commercialized
No
Company Name
Neuraxpharm Spain S.L.
Active Ingredients
LEVETIRACETAM
500 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Nov 23, 2020
Approval ID
c85f3333b29e4ced
Type
Standard
Back to CIMA-AEMPS Approvals